Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference
Accolade, Inc. - common stock (ACCD)
Company Research
Source: GlobeNewswire
SEATTLE, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Thursday, September 5 at 9:15 am ET. A webcast will be available at ir.accolade.com and a replay will be available for 90 days. About Accolade, Inc. Accolade?(Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfactio
Show less
Read more
Impact Snapshot
Event Time:
ACCD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACCD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACCD alerts
High impacting Accolade, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
ACCD
News
- Accolade To Present at Upcoming Investor ConferencesGlobeNewswire
- Accolade And 2 Other Penny Stocks To Watch On US Exchanges [Yahoo! Finance]Yahoo! Finance
- Accolade Welcomes Renalogic to Trusted Partner EcosystemPR Newswire
- Accolade, Inc. (NASDAQ: ACCD) had its price target lowered by analysts at Wells Fargo & Company from $7.00 to $6.00. They now have an "equal weight" rating on the stock.MarketBeat
- Accolade, Inc. (NASDAQ: ACCD) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $13.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
ACCD
Earnings
- 10/8/24 - Beat
ACCD
Sec Filings
- 11/20/24 - Form 4
- 11/20/24 - Form 4
- 11/20/24 - Form 4
- ACCD's page on the SEC website